Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Laurène Dufayet, Fleur Monnet, Hervé Laborde-Casterot, Weniko Caré, Béranger Lekens, Jérôme Langrand, Bruno Mégarbane & Dominique Vodovar. (2021) Unintentional exposure to pregabalin in ≤6-year-old children: a nationwide French Poison Control Center study. Clinical Toxicology 59:5, pages 433-439.
Read now
Read now
Hon Sen Tan, Zach Frere, Vijay Krishnamoorthy, Tetsu Ohnuma, Karthik Raghunathan & Ashraf S. Habib. (2021) Association of gabapentinoid utilization with postoperative pulmonary complications in gynecologic surgery: a retrospective cohort study. Current Medical Research and Opinion 37:5, pages 821-828.
Read now
Read now
Kimberly Reynolds, Robert Kaufman, Amanda Korenoski, Laura Fennimore, Joshua Shulman & Michael Lynch. (2020) Trends in gabapentin and baclofen exposures reported to U.S. poison centers. Clinical Toxicology 58:7, pages 763-772.
Read now
Read now
Justin P. Reinert & Rebecca L. Dunn. (2019) Management of overdoses of loperamide, gabapentin, and modafinil: a literature review. Expert Review of Clinical Pharmacology 12:9, pages 901-908.
Read now
Read now
Kiran A. Faryar, Ashley N. Webb, Bikash Bhandari, Timothy G. Price & George M. Bosse. (2019) Trending gabapentin exposures in Kentucky after legislation requiring use of the state prescription drug monitoring program for all opioid prescriptions. Clinical Toxicology 57:6, pages 398-403.
Read now
Read now
Nicole M Ryan. (2015) A review on the efficacy and safety of gabapentin in the treatment of chronic cough. Expert Opinion on Pharmacotherapy 16:1, pages 135-145.
Read now
Read now
. (2014) XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 27–30 May 2014, Brussels, Belgium. Clinical Toxicology 52:4, pages 295-443.
Read now
Read now
Cédric Daubin, Charlotte Quentin, Jean-Pierre Goullé, Damien Guillotin, Philippe Lehoux, Olivier Lepage & Pierre Charbonneau. (2007) Refractory shock and asystole related to tramadol overdose. Clinical Toxicology 45:8, pages 961-964.
Read now
Read now
John J. Mariani, Richard N. Rosenthal, Susan Tross, Prameet Singh & Om P. Anand. (2006) A Randomized, Open-Label, Controlled Trial of Gabapentin and Phenobarbital in the Treatment of Alcohol Withdrawal. American Journal on Addictions 15:1, pages 76-84.
Read now
Read now
Articles from other publishers (51)
Hae Sung Kang, Travis M. Sullivan, Rebecca Zee, Victoria G. Kuester & Jason P. Sulkowski. (2024) Gabapentin May Not Decrease Opioid Use in Pediatric Enhanced Recovery After Surgery Protocols. Journal of Surgical Research 294, pages 169-175.
Crossref
Crossref
Ved Vasishtha Pendyala, Sarah Pribil, Victoria Schaal, Kanika Sharma, Sankarasubramanian Jagadesan, Li Yu, Vikas Kumar, Chittibabu Guda & Lie Gao. (2023) Effects of Acute and Chronic Gabapentin Treatment on Cardiovascular Function of Rats. Cells 12:23, pages 2705.
Crossref
Crossref
Meghan A. Corriere, Laura L. Daniel, Alyson L. Dickson, Puran Nepal, Kathi Hall, W. Dale Plummer, William D. Dupont, Katherine T. Murray, C. Michael Stein, Wayne A. Ray & Cecilia P. Chung. (2023) Concurrent Gabapentin and Opioid Use and Risk of Mortality in Medicare Recipients with Non‐Cancer Pain. Clinical Pharmacology & Therapeutics 114:5, pages 1050-1057.
Crossref
Crossref
Jamir Pitton Rissardo, Ursula Medeiros Araujo de Matos & Ana Letícia Fornari Caprara. (2023) Gabapentin-Associated Movement Disorders: A Literature Review. Medicines 10:9, pages 52.
Crossref
Crossref
Reuben J. Strayer, Benjamin W. Friedman, Rachel Haroz, Eric Ketcham, Lauren Klein, Alexis M. LaPietra, Sergey Motov, Zachary Repanshek, Scott Taylor, Scott G. Weiner & Lewis S. Nelson. (2023) Emergency Department Management of Patients With Alcohol Intoxication, Alcohol Withdrawal, and Alcohol Use Disorder: A White Paper Prepared for the American Academy of Emergency Medicine. The Journal of Emergency Medicine 64:4, pages 517-540.
Crossref
Crossref
Josée Bouchard, Christopher Yates, Diane P. Calello, Sophie Gosselin, Darren M. Roberts, Valéry Lavergne, Robert S. Hoffman, Marlies Ostermann, Ai Peng, Marc Ghannoum, Badria Alhatali, Kurt Anseeuw, Steven Bird, Ingrid Berling, Timothy E. Bunchman, Paul K. Chin, Kent Doi, Tais Galvao, David S. Goldfarb, Hossein Hassanian, Lotte C.G. Hoegberg, Siba Kallab, Sofia Kebede, Jan T. Kielstein, Andrew Lewington, Etienne M. Macedo, Rob MacLaren, Bruno Megarbane, James B. Mowry, Thomas D. Nolin, Jean-Philippe Roy, Anitha Vijayan, Steven J. Walsh, Anselm Wong & David M. Wood. (2022) Extracorporeal Treatment for Gabapentin and Pregabalin Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. American Journal of Kidney Diseases 79:1, pages 88-104.
Crossref
Crossref
Kirk E. Evoy, Jordan R. Covvey, Alyssa M. Peckham & Kelly R. Reveles. (2021) Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample. International Journal of Clinical Pharmacy 43:4, pages 1055-1064.
Crossref
Crossref
Rami Algahtani & Amedeo Merenda. (2020) Multimorbidity and Critical Care Neurosurgery: Minimizing Major Perioperative Cardiopulmonary Complications. Neurocritical Care 34:3, pages 1047-1061.
Crossref
Crossref
Sophie Bargel, Jenny Becam, Lucie Chanu, Thomas Lanot, Marie Martin, Jules Vaucel, Theo Willeman & Nicolas Fabresse. (2021) Les gabapentinoïdes : une revue de la littérature. Toxicologie Analytique et Clinique 33:1, pages 44-63.
Crossref
Crossref
Staffan Hägg, Anna K. Jönsson & Johan Ahlner. (2020) Current Evidence on Abuse and Misuse of Gabapentinoids. Drug Safety 43:12, pages 1235-1254.
Crossref
Crossref
Crispiana Cozowicz, Janis Bekeris, Jashvant Poeran, Nicole Zubizarreta, Eric Schwenk, Federico Girardi & Stavros G. Memtsoudis. (2020) Multimodal Pain Management and Postoperative Outcomes in Lumbar Spine Fusion Surgery. Spine 45:9, pages 580-589.
Crossref
Crossref
Michael D. Stein, Shannon R. Kenney, Bradley J. Anderson, Micah T. Conti & Genie L. Bailey. (2020) Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification. Journal of Substance Abuse Treatment 110, pages 37-41.
Crossref
Crossref
Evangelia Mareti, Christina Ampatzi, Stavroula A. Paschou, Evangelia Voziki & Dimitrios G. Goulis. (2019) Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?. Current Vascular Pharmacology 17:6, pages 573-578.
Crossref
Crossref
Xiaoliang Qiu, Eva Tackett & Zeid Khitan. (2019) A case of gabapentin overdose induced rhabdomyolysis requiring renal replacement therapy. Clinical Case Reports 7:8, pages 1596-1599.
Crossref
Crossref
Sharon L. Crowell‐Davis, Thomas F. Murray & Leticia Mattos DantasSharon L. Crowell‐Davis, Mami Irimajiri & Leticia Mattos de Souza Dantas. 2019. Veterinary Psychopharmacology. Veterinary Psychopharmacology
147
156
.
Silvia Ferranti, Elisabetta Grande, Carla Gaggiano & Salvatore Grosso. (2018) Antiepileptic drugs: Role in paediatric poisoning. Journal of Paediatrics and Child Health 54:5, pages 475-479.
Crossref
Crossref
H. Karl Greenblatt & David J. Greenblatt. (2018) Gabapentin and Pregabalin for the Treatment of Anxiety Disorders. Clinical Pharmacology in Drug Development 7:3, pages 228-232.
Crossref
Crossref
U. Bonnet & N. Scherbaum. (2017) How addictive are gabapentin and pregabalin? A systematic review. European Neuropsychopharmacology 27:12, pages 1185-1215.
Crossref
Crossref
Mance E. Buttram, Steven P. Kurtz, Richard C. Dart & Zachary R. Margolin. (2017) Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings. Pharmacoepidemiology and Drug Safety 26:9, pages 1083-1086.
Crossref
Crossref
Alyssa M. Peckham, Kathleen A. Fairman & David A. Sclar. (2017) Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population. Clinical Drug Investigation 37:8, pages 763-773.
Crossref
Crossref
Alexandre N. CavalcanteJuraj SprungDarrell R. SchroederToby N. Weingarten. (2017) Multimodal Analgesic Therapy With Gabapentin and Its Association With Postoperative Respiratory Depression. Anesthesia & Analgesia 125:1, pages 141-146.
Crossref
Crossref
Kirk E. Evoy, Megan D. Morrison & Stephen R. Saklad. (2017) Abuse and Misuse of Pregabalin and Gabapentin. Drugs 77:4, pages 403-426.
Crossref
Crossref
M. P. Emswiler & K. L. Cumpston. 2017. Critical Care Toxicology. Critical Care Toxicology
1
18
.
M. P. Emswiler & Kirk L. Cumpston. 2017. Critical Care Toxicology. Critical Care Toxicology
1065
1081
.
Rachel V. Smith, Jennifer R. Havens & Sharon L. Walsh. (2016) Gabapentin misuse, abuse and diversion: a systematic review. Addiction 111:7, pages 1160-1174.
Crossref
Crossref
M. P. Emswiler & K. L. Cumpston. 2016. Critical Care Toxicology. Critical Care Toxicology
1
18
.
Jonathan G. Leung, Daniel Hall-Flavin, Sarah Nelson, Kristen A. Schmidt & Kathryn M. Schak. (2015) The Role of Gabapentin in the Management of Alcohol Withdrawal and Dependence. Annals of Pharmacotherapy 49:8, pages 897-906.
Crossref
Crossref
Shady S. Shebak, Megan D. Whitham, Andrew D. Snyder, Robert J. Varipapa & Thomas R. Milam. (2015) Potential for Increase in Gabapentin Associated Complications with Its Increased Availability. Substance Abuse, pages 00-00.
Crossref
Crossref
Brandon Wills, Penny Reynolds, Eileen Chu, Christine Murphy, Kirk Cumpston, Paul Stromberg & Rutherfoord Rose. (2014) Clinical Outcomes in Newer Anticonvulsant Overdose: A Poison Center Observational Study. Journal of Medical Toxicology 10:3, pages 254-260.
Crossref
Crossref
Margareeta Häkkinen, Erkki Vuori, Eija Kalso, Merja Gergov & Ilkka Ojanperä. (2014) Profiles of pregabalin and gabapentin abuse by postmortem toxicology. Forensic Science International 241, pages 1-6.
Crossref
Crossref
Robert H. Howland. (2014) Gabapentin for Substance Use Disorders: Is it Safe and Appropriate?. Journal of Psychosocial Nursing and Mental Health Services 52:2, pages 13-16.
Crossref
Crossref
Peter C. Schmidt, Gabriela Ruchelli, Sean C. Mackey & Ian R. Carroll. (2013) Perioperative Gabapentinoids. Anesthesiology 119:5, pages 1215-1221.
Crossref
Crossref
Allister Vale. (2012) Anticonvulsants. Medicine 40:2, pages 96-97.
Crossref
Crossref
Owen Middleton. (2011) Suicide by Gabapentin Overdose. Journal of Forensic Sciences 56:5, pages 1373-1375.
Crossref
Crossref
Lindsay Murray, Frank Daly, Mark Little & Mike Cadogan. 2011. Toxicology Handbook. Toxicology Handbook
127
370
.
Sebastian Bauer, G. David Rudd, Veit Mylius, Hajo M. Hamer & Felix Rosenow. (2010) Lacosamide intoxication in attempted suicide. Epilepsy & Behavior 17:4, pages 549-551.
Crossref
Crossref
Jeffrey F. Wade, Chat V. Dang, Lowell Nelson & Jonathan Wasserberger. (2010) Emergent Complications of the Newer Anticonvulsants. The Journal of Emergency Medicine 38:2, pages 231-237.
Crossref
Crossref
Henry McQuayP. M. Lavand’homme & M. F. De Kock. 2009. Acute Pain Management. Acute Pain Management
82
101
.
Alice Miller & Grant Price. (2009) Gabapentin Toxicity in Renal Failure: The Importance of Dose Adjustment. Pain Medicine 10:1, pages 190-192.
Crossref
Crossref
Kara A. Kennedy & Melody Ryan. 2009. Clinical Neurotoxicology. Clinical Neurotoxicology
358
371
.
Kirk J. Brower, Hyungjin Myra Kim, Stephen Strobbe, Maher A. Karam-Hage, Flavia Consens & Robert A. Zucker. (2008) A Randomized Double-Blind Pilot Trial of Gabapentin Versus Placebo to Treat Alcohol Dependence and Comorbid Insomnia. Alcoholism: Clinical and Experimental Research 32:8, pages 1429-1438.
Crossref
Crossref
Katsuhiro Kobayashi, Akihito Takeuchi, Makio Oka, Fumika Endoh, Harumi Yoshinaga & Yoko Ohtsuka. (2008) Dramatic Aggravation of Partial Seizures Induced by Gabapentin Overdose. Epilepsy & Seizure 1:1, pages 40-46.
Crossref
Crossref
Allister Vale. (2007) Anticonvulsants. Medicine 35:11, pages 585-586.
Crossref
Crossref
A. J. Braga & K. Chidley. (2007) Self-poisoning with lamotrigine and pregabalin. Anaesthesia 62:5, pages 524-527.
Crossref
Crossref
Michael J Gonyeau & Christina A Rooney. (2016) Should Gabapentin Be Dose Adjusted: What are the Clinical Consequences?. Journal of Pharmacy Technology 23:1, pages 30-34.
Crossref
Crossref
Joseph J. Rasimas & Keith K. Burkhart. (2006) Cardiac conduction disturbances after an overdose of nefazodone and gabapentin. The American Journal of Emergency Medicine 24:7, pages 886-888.
Crossref
Crossref
Thomas Bookwalter & Matthew Gitlin. (2005) Gabapentin-Induced Neurologic Toxicities. Pharmacotherapy 25:12, pages 1817-1819.
Crossref
Crossref
Ph. Hantson. (2005) Nouveaux anti-épileptiques : quelle toxicité en cas d’intoxication aiguë ?. Journal Européen des Urgences 18:4, pages 221-226.
Crossref
Crossref
Terry D FifeJoseph Sirven. (2005) Antiepileptic drugs and their impact on balance. Aging Health 1:1, pages 147-155.
Crossref
Crossref
Antonio Gil-Nagel. 2005. Side Effects of Drugs Annual 28. Side Effects of Drugs Annual 28
86
105
.
C Hansen, I Gilron & M Hong. (2004) The Effects of Intrathecal Gabapentin on Spinal Morphine Tolerance in the Rat Tail-Flick and Paw Pressure Tests. Anesthesia & Analgesia 99:4, pages 1180-1184.
Crossref
Crossref